Traders Purchase Large Volume of Tilray Call Options (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) saw some unusual options trading on Friday. Stock traders bought 72,984 call options on the stock. This is an increase of 61% compared to the typical daily volume of 45,257 call options.

Tilray Stock Performance

Tilray stock opened at $1.23 on Friday. The company’s 50-day moving average price is $1.36 and its 200-day moving average price is $1.62. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.11 billion, a PE ratio of -4.56 and a beta of 2.08. Tilray has a twelve month low of $1.14 and a twelve month high of $2.97.

Tilray (NASDAQ:TLRY) last announced its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to analysts’ expectations of $216.34 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, equities research analysts forecast that Tilray will post -0.14 EPS for the current fiscal year.

Insider Activity at Tilray

In other news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction dated Friday, November 15th. The shares were purchased at an average cost of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.87% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tilray

A number of institutional investors and hedge funds have recently modified their holdings of TLRY. JPMorgan Chase & Co. lifted its holdings in Tilray by 32.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 432,031 shares of the company’s stock valued at $760,000 after buying an additional 105,803 shares in the last quarter. Synovus Financial Corp raised its stake in shares of Tilray by 176.7% during the third quarter. Synovus Financial Corp now owns 36,092 shares of the company’s stock valued at $64,000 after acquiring an additional 23,046 shares in the last quarter. Barclays PLC boosted its holdings in shares of Tilray by 600.4% in the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock valued at $359,000 after purchasing an additional 174,997 shares during the period. Toronto Dominion Bank grew its stake in Tilray by 454.5% in the third quarter. Toronto Dominion Bank now owns 128,923 shares of the company’s stock worth $227,000 after purchasing an additional 105,671 shares in the last quarter. Finally, XTX Topco Ltd increased its holdings in Tilray by 1,079.7% during the 3rd quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after purchasing an additional 257,641 shares during the period. 9.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Roth Mkm lowered their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.